EUVIMEDEUVIMED entdecken
Multizentrische StudieRandomisierte kontrollierte StudieOpen Access · CC BY 4.0

Fentanyl or morphine for persistent dyspnoea in COPD: a multicentre randomised crossover trial

Marlies van Dijk iD, Kris J M Mooren, Wendy van Beurden-Moeskops, Roxane Heller-Baan, Sander M de Hosson, Remge M Pieterman, Wai Yee Lam-Wong, Liesbeth Peters, Karin Pool, Jan-Willem K van den Berg iD, Huib A M Kerstjens iD

European Respiratory Journal · 2026-08 · 68 (2) · 2501431

DOI: 10.1183/13993003.01431-2025 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift European Respiratory Journal, online erschienen am 04.06.2026. Verfasst von Marlies van Dijk und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pulmonary Diseases, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands m.van.dijk05@umcg.nl. Hauptthemen laut MEDLINE: Pulmonary Disease, Chronic Obstructive, Dyspnea, Morphine, Fentanyl. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Stichting Astma Bestrijding, Innovatiefonds Zorgverzekeraars.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

One of the most prevalent and impactful symptoms in COPD is persistent dyspnoea, occurring in the majority of patients with advanced COPD. Opioids, mostly morphine, have been investigated and suggested as treatment in palliative care guidelines. However, in recent years multiple trials on morphine for persistent dyspnoea have shown no clinical benefit, and there are concerns regarding adverse events. Transdermal fentanyl has not yet been investigated for this indication.

Methods

We performed a multicentre, crossover, double-dummy randomised controlled trial, investigating transdermal fentanyl (12 μg·h −1 ), morphine (10 mg per os twice daily) and placebo, during three treatment periods of 2 weeks (including a 3-day washout period). Patients with persistent dyspnoea despite optimal therapy and modified Medical Research Council dyspnoea scale score ≥3 caused by COPD, forced expiratory volume in 1 s (FEV 1 )

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pulmonary Disease, Chronic ObstructiveDyspneaMorphineFentanylAnalgesics, OpioidHumansCross-Over StudiesFemaleAgedMaleDouble-Blind MethodForced Expiratory VolumeMiddle AgedAdministration, CutaneousTreatment OutcomeSurveys and QuestionnairesHypercapniaAnxietySleep Quality

Substanzen

MorphineFentanylAnalgesics, Opioid

Autor:innen und Institutionen

  • Department of Pulmonary Diseases, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands m.van.dijk05@umcg.nl.
  • Groningen Research Institute of Asthma and COPD (GRIAC), University of Groningen, Groningen, The Netherlands.
  • Department of Pulmonary Diseases, Spaarne Gasthuis, Haarlem, The Netherlands.
  • Department of Pulmonary Diseases, Medisch Spectrum Twente, Enschede, The Netherlands.
  • Department of Pulmonary Diseases, Ikazia Ziekenhuis, Rotterdam, The Netherlands.
  • Department of Pulmonary Diseases, Wilhelmina Ziekenhuis Assen, Assen, The Netherlands.

ORCID-Profile: Marlies van Dijk, Jan-Willem K van den Berg, Huib A M Kerstjens

Förderung

  • Stichting Astma Bestrijding
  • Innovatiefonds Zorgverzekeraars

Zitieren

APA

van Dijk, M., Mooren, K. J. M., van Beurden-Moeskops, W., Heller-Baan, R., de Hosson, S. M., Pieterman, R. M., Lam-Wong, W. Y., Peters, L., Pool, K., van den Berg, J. K., & Kerstjens, H. A. M. (2026). Fentanyl or morphine for persistent dyspnoea in COPD: a multicentre randomised crossover trial. European Respiratory Journal, 68(2), 2501431. https://doi.org/10.1183/13993003.01431-2025

Vancouver

van Dijk M, Mooren KJM, van Beurden-Moeskops W, Heller-Baan R, de Hosson SM, Pieterman RM, et al. Fentanyl or morphine for persistent dyspnoea in COPD: a multicentre randomised crossover trial. European Respiratory Journal. 2026;68(2):2501431. doi:10.1183/13993003.01431-2025

BibTeX
@article{vanDijk2026,
  author = {van Dijk, Marlies and Mooren, Kris J M and van Beurden-Moeskops, Wendy and Heller-Baan, Roxane and de Hosson, Sander M and Pieterman, Remge M and Lam-Wong, Wai Yee and Peters, Liesbeth and Pool, Karin and van den Berg, Jan-Willem K and Kerstjens, Huib A M},
  title = {Fentanyl or morphine for persistent dyspnoea in COPD: a multicentre randomised crossover trial},
  journal = {European Respiratory Journal},
  year = {2026},
  volume = {68},
  number = {2},
  pages = {2501431},
  doi = {10.1183/13993003.01431-2025}
}
Kostenlos starten →